Our colleagues Ingo Lehrke, CBO, and Jonas Helma-Smets, CSO, are looking forward to participating in the upcoming #BIO2024 Convention, starting next week in #SanDiego. If you want to discuss the future in #ADC development and learn more about our suite of trailblazing technologies to generate uniquely matched, indication-specific ADCs, with the start of our first #ClinicalTrial just ahead, reach out to us via the partnering system for a 1:1 meeting. For an overview of our platforms, pipeline candidates and #SolidTumor target indications, visit www.tubulis.com.
Tubulis GmbH’s Post
More Relevant Posts
-
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSᵃⁱ™ Technology. The 2024 Impact Award, sponsored by InterSystems, acknowledges BioStrand’s innovative LENSᵃⁱ technology, selected from over 1,000 client projects for its remarkable contributions. The selection committee, chaired by Professor Roberto Zicari, identified BioStrand’s work based on three key criteria: makes a significant difference, breaks new ground and sets an example. Tune in to today's Main Stage live to see the award presentation from 10:30-11:00am ET : https://bit.ly/3RtxGGP See the full release: https://bit.ly/3RonJur #GlobalSummit24 #TechBio #VectorSearch #DrugDiscovery #Biotech #ArtificialIntelligence #Antibodies #OmicsData BioStrand (a subsidiary of IPA)
-
-
Learn more about Depixus at depixus.com
Depixus very much enjoyed #BostonDOT23! Our President & CEO, Gordon Hamilton, gave talk on “Magnetic force spectroscopy – a novel approach to Improve the hit-to-lead and lead optimization phases of RNA-targeted small-molecule drug discovery.” The talk received excellent engagement from the audience, as indicated by the sheer number of great questions at the end! Gordon Hamilton will also be delivering a webinar entitled 'Transforming RNA-targeted drug discovery with MAGNA', 10:30am EDT/4:30pm CEST on Wednesday 11th October. You can register at depixus.com/webinars @Cambridge HealthTech Institute #DrugDiscovery #BostonDOT23 #RNA#SmallMolecules #DrugTargets #Biotech #Spectroscopy
-
-
#Singlecell Omics is a hot topic for #FOGBoston next week, and Scale Biosciences can't wait! Don't miss our talk at the Live Lounge on June 12, and be sure to join us at booth 10 to talk about #methylation, #RNAseq, #CRISPR, and more, brought to you, finally, at SCALE.
-
Please join us for our last webinar in the biotech series around optimizing launch -- should make for a fascinating discussion!
Last chance to join our exclusive webinar series tailored for commercial and market access biotech professionals. Make sure to save your seat today to get insights! skp.link/2fz #BiotechWebinar #BiotechnologyIndustry #MarketAccess #SKEvent #SimonKucher #BetterGrowth
-
Last chance to join our exclusive webinar series tailored for commercial and market access biotech professionals. Make sure to save your seat today to get insights! skp.link/2fz #BiotechWebinar #BiotechnologyIndustry #MarketAccess #SKEvent #SimonKucher #BetterGrowth
-
During the past three months, Cybin has made exciting progress with positive topline data from our CYB003 and DMT clinical trials, forming the foundation of our next set of value-creating milestones as we advance our key programs this year. Learn more: https://lnkd.in/ggsH2VvR #MentalHealthInnovation #ResearchAndDevelopment #CYB003 #DMT #researchanddevelopment #cybin #psychedelicresearch #clinicalresearch #mentalhealthresearch #DrugDevelopment #Biotech #MentalHealth #researchanddevelopment #cybin #psychedelicresearch #clinicalresearch #mentalhealthresearch #ChangingMinds #OpenMinds #psychedelicresearch #clinicalresearch
-
Catch up with the latest Cresset news in our March newsletter, where we share our latest results for GPCR benchmarks using Flare™ FEP along with all our latest updates including: 🏆 Cresset wins Bionow Internationalisation Award 💻 Webinar 'Enhancing collaboration in drug discovery - a biotech perspective' 📢 Speaker announcements for our Cresset User Group Meeting in June ⚡ Solutions for virtual screening enumerated libraries and combinatorial spaces https://obi41.nl/4eaxy5ms For monthly updates direct to your inbox, subscribe to our newsletter at the above link and be the first to hear about our latest news, case studies, expert scientific opinion and events to support you with your small molecule discovery. #DMTA #drugdiscovery #drugdesign #computationalchemistry #compchem #medicinalchemistry #medchem #CADD #preclinicalresearch
-
The overall picture of the Swiss biotech industry is quite positive. The Swiss Biotech Report recently published provides an analysis of the 2023 biotech funding as well as other key ratios and statistics: https://lnkd.in/dGSvh2d With Swiss Biotech Association https://lnkd.in/dAtS7hyU
-
Curious about the transformative power of IceCure Medical’s LN2-based #ProSense #Cryoablation System? Watch our new video to find out how we’re revolutionizing the field of #interventionalradiology, one freeze at a time. ❄️ #MedTech #BioTech #MedicalDevice #InterventionalOncogoly #WomensHealth
-
Building back biomanufacturing resilience must remain a top priority for our industry. Listen in as #CDMO Arranta Bio shares its considerations and lessons learned around #mRNA production capacity. https://lnkd.in/emDK-5Y5 #genetherapy #cellandgenetherapy
CBO at Tubulis & CEO at Algiax
2mocan´t wait to get there and meet old friends and partners as well as getting to know new colleagues and potential partners